US EditionPublished • loading... • Updated
Moderna Eyes 2028 Breakeven as COVID Sales Continue to Drop
Summary by NBC Boston
2 Articles
2 Articles
Moderna Projects Lower Revenue in 2025 Due to Flagging COVID-19 Vaccine Sales
Moderna on Nov. 6 revised its revenue projections for 2025 after third-quarter sales plummeted from a year prior. Moderna made just $1 billion in the third quarter, down 45 percent from the $1.9 billion it made in the third quarter of 2024. The drop was primarily driven by a 47 percent decrease in sales, mainly sales of the company’s COVID-19 vaccines. Sales were down $847 million, or 47 percent, compared with the third quarter of 2024. In the U…
·New York, United States
Read Full Article
Coverage Details
Total News Sources2
Leaning Left1Leaning Right1Center0Last UpdatedBias Distribution50% Left, 50% Right
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
50% Right
L 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
